Arguments in favour of remdesivir for treating SARS-CoV-2 infections

doi:10.1016/j.ijantimicag.2020.105933

Editorial

. 2020 Apr;55(4):105933.

doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.

Arguments in favour of remdesivir for treating SARS-CoV-2 infections

Wen-Chien Ko¹, Jean-Marc Rolain², Nan-Yao Lee¹, Po-Lin Chen¹, Ching-Tai Huang³, Ping-Ing Lee⁴, Po-Ren Hsueh⁵

Affiliations

¹ Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Center for Infection Control and Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
² Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), Assistance 7 Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 8 Marseille, France; IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France.
³ Department of Infectious Diseases, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
⁴ Department of Pediatrics, National Taiwan University Children's Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
⁵ Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.

PMID: 32147516
PMCID: PMC7135364
DOI: 10.1016/j.ijantimicag.2020.105933

Editorial

Arguments in favour of remdesivir for treating SARS-CoV-2 infections

Wen-Chien Ko et al. Int J Antimicrob Agents. 2020 Apr.

. 2020 Apr;55(4):105933.

doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.

Authors

Wen-Chien Ko¹, Jean-Marc Rolain², Nan-Yao Lee¹, Po-Lin Chen¹, Ching-Tai Huang³, Ping-Ing Lee⁴, Po-Ren Hsueh⁵

Affiliations

¹ Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Center for Infection Control and Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
² Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), Assistance 7 Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 8 Marseille, France; IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France.
³ Department of Infectious Diseases, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
⁴ Department of Pediatrics, National Taiwan University Children's Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
⁵ Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.

PMID: 32147516
PMCID: PMC7135364
DOI: 10.1016/j.ijantimicag.2020.105933

No abstract available

Keywords: Betacoronavirus; COVID-19; Coronavirus disease 2019; Remdesivir; SARS-CoV-2; Wuhan pneumonia.

PubMed Disclaimer

Cited by

COVID-19 Drug Treatment in China.
Fan L, Jiang S, Yang X, Wang Z, Yang C. Fan L, et al. Curr Pharmacol Rep. 2020;6(4):146-154. doi: 10.1007/s40495-020-00218-5. Epub 2020 Sep 7. Curr Pharmacol Rep. 2020. PMID: 32837851 Free PMC article. Review.
Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2.
Fadaka AO, Sibuyi NRS, Adewale OB, Bakare OO, Akanbi MO, Klein A, Madiehe AM, Meyer M. Fadaka AO, et al. J Int Med Res. 2020 Aug;48(8):300060520949077. doi: 10.1177/0300060520949077. J Int Med Res. 2020. PMID: 32842818 Free PMC article. Review.
COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications.
Yamamoto V, Bolanos JF, Fiallos J, Strand SE, Morris K, Shahrokhinia S, Cushing TR, Hopp L, Tiwari A, Hariri R, Sokolov R, Wheeler C, Kaushik A, Elsayegh A, Eliashiv D, Hedrick R, Jafari B, Johnson JP, Khorsandi M, Gonzalez N, Balakhani G, Lahiri S, Ghavidel K, Amaya M, Kloor H, Hussain N, Huang E, Cormier J, Wesson Ashford J, Wang JC, Yaghobian S, Khorrami P, Shamloo B, Moon C, Shadi P, Kateb B. Yamamoto V, et al. J Alzheimers Dis. 2020;77(2):459-504. doi: 10.3233/JAD-200831. J Alzheimers Dis. 2020. PMID: 32925078 Free PMC article. Review.
The recent challenges of highly contagious COVID-19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy.
Mohapatra RK, Pintilie L, Kandi V, Sarangi AK, Das D, Sahu R, Perekhoda L. Mohapatra RK, et al. Chem Biol Drug Des. 2020 Nov;96(5):1187-1208. doi: 10.1111/cbdd.13761. Epub 2020 Jul 26. Chem Biol Drug Des. 2020. PMID: 32654267 Free PMC article. Review.
Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review.
Barati F, Pouresmaieli M, Ekrami E, Asghari S, Ziarani FR, Mamoudifard M. Barati F, et al. Biol Proced Online. 2020 Jul 23;22:15. doi: 10.1186/s12575-020-00129-1. eCollection 2020. Biol Proced Online. 2020. PMID: 32754003 Free PMC article. Review.

See all "Cited by" articles

References

1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
1. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020 Jan 29 doi: 10.1056/NEJMoa2001316. [Epub ahead of print] - DOI - PMC - PubMed
1. Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523. doi: 10.1016/S0140-6736(20)30154-9. - DOI - PMC - PubMed
1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
Miscellaneous
- NCI CPTAC Assay Portal

[1] Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed

[2] Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed

[3] Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020 Jan 29 doi: 10.1056/NEJMoa2001316. [Epub ahead of print] - DOI - PMC - PubMed

[4] Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020 Jan 29 doi: 10.1056/NEJMoa2001316. [Epub ahead of print] - DOI - PMC - PubMed

[5] Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523. doi: 10.1016/S0140-6736(20)30154-9. - DOI - PMC - PubMed

[6] Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523. doi: 10.1016/S0140-6736(20)30154-9. - DOI - PMC - PubMed

[7] Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed

[8] Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed

[9] Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7. - DOI - PMC - PubMed

[10] Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Arguments in favour of remdesivir for treating SARS-CoV-2 infections

Affiliations

Arguments in favour of remdesivir for treating SARS-CoV-2 infections

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous